Polipéptidos que se unen a CXCR2
La presente invención se refiere a polipéptidos dirigidos contra el receptor de quimiocina CXCR2 o que se unen específicamente a él y en particular a polipéptidos capaces de modular la transducción de señales a partir de CXCR2. La invención también se refiere a ácidos nucleicos, vectores y células h...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BROWN, Zarin DOMBRECHT, Bruno CROMIE, Karen STEFFENSEN, Soren CHARLTON, Steven John BRADLEY, Michelle VAN HEEKE, Gino |
| description | La presente invención se refiere a polipéptidos dirigidos contra el receptor de quimiocina CXCR2 o que se unen específicamente a él y en particular a polipéptidos capaces de modular la transducción de señales a partir de CXCR2. La invención también se refiere a ácidos nucleicos, vectores y células huésped capaces de expresar los polipéptidos de la invención, composiciones farmacéuticas que comprenden los polipéptidos y usos de dichos polipéptidos y composiciones para el tratamiento de enfermedades que implican el funcionamiento aberrante de CXCR2. (Traducción automática con Google Translate, sin valor legal)
The present invention relates to polypeptides directed against or specifically binding to chemokine receptor CXCR2 and in particular to polypeptides capable of modulating signal transduction from CXCR2. The invention also relates to nucleic acids, vectors and host cells capable of expressing the polypeptides of the invention, pharmaceutical compositions comprising the polypeptides and uses of said polypeptides and compositions for treatment of diseases involving aberrant functioning of CXCR2. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2970234TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2970234TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2970234TT33</originalsourceid><addsrcrecordid>eNrjZFAMyM_JLDi8sqAkMyW_WKGwNFWhOFWhNC81TyFRwTnCOciIh4E1LTGnOJUXSnMzKLq5hjh76KYW5MenFhckJqfmpZbEuwYbWZobGBmbhIQYGxOjBgB-8yW_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Polipéptidos que se unen a CXCR2</title><source>esp@cenet</source><creator>BROWN, Zarin ; DOMBRECHT, Bruno ; CROMIE, Karen ; STEFFENSEN, Soren ; CHARLTON, Steven John ; BRADLEY, Michelle ; VAN HEEKE, Gino</creator><creatorcontrib>BROWN, Zarin ; DOMBRECHT, Bruno ; CROMIE, Karen ; STEFFENSEN, Soren ; CHARLTON, Steven John ; BRADLEY, Michelle ; VAN HEEKE, Gino</creatorcontrib><description>La presente invención se refiere a polipéptidos dirigidos contra el receptor de quimiocina CXCR2 o que se unen específicamente a él y en particular a polipéptidos capaces de modular la transducción de señales a partir de CXCR2. La invención también se refiere a ácidos nucleicos, vectores y células huésped capaces de expresar los polipéptidos de la invención, composiciones farmacéuticas que comprenden los polipéptidos y usos de dichos polipéptidos y composiciones para el tratamiento de enfermedades que implican el funcionamiento aberrante de CXCR2. (Traducción automática con Google Translate, sin valor legal)
The present invention relates to polypeptides directed against or specifically binding to chemokine receptor CXCR2 and in particular to polypeptides capable of modulating signal transduction from CXCR2. The invention also relates to nucleic acids, vectors and host cells capable of expressing the polypeptides of the invention, pharmaceutical compositions comprising the polypeptides and uses of said polypeptides and compositions for treatment of diseases involving aberrant functioning of CXCR2.</description><language>spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240527&DB=EPODOC&CC=ES&NR=2970234T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240527&DB=EPODOC&CC=ES&NR=2970234T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BROWN, Zarin</creatorcontrib><creatorcontrib>DOMBRECHT, Bruno</creatorcontrib><creatorcontrib>CROMIE, Karen</creatorcontrib><creatorcontrib>STEFFENSEN, Soren</creatorcontrib><creatorcontrib>CHARLTON, Steven John</creatorcontrib><creatorcontrib>BRADLEY, Michelle</creatorcontrib><creatorcontrib>VAN HEEKE, Gino</creatorcontrib><title>Polipéptidos que se unen a CXCR2</title><description>La presente invención se refiere a polipéptidos dirigidos contra el receptor de quimiocina CXCR2 o que se unen específicamente a él y en particular a polipéptidos capaces de modular la transducción de señales a partir de CXCR2. La invención también se refiere a ácidos nucleicos, vectores y células huésped capaces de expresar los polipéptidos de la invención, composiciones farmacéuticas que comprenden los polipéptidos y usos de dichos polipéptidos y composiciones para el tratamiento de enfermedades que implican el funcionamiento aberrante de CXCR2. (Traducción automática con Google Translate, sin valor legal)
The present invention relates to polypeptides directed against or specifically binding to chemokine receptor CXCR2 and in particular to polypeptides capable of modulating signal transduction from CXCR2. The invention also relates to nucleic acids, vectors and host cells capable of expressing the polypeptides of the invention, pharmaceutical compositions comprising the polypeptides and uses of said polypeptides and compositions for treatment of diseases involving aberrant functioning of CXCR2.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAMyM_JLDi8sqAkMyW_WKGwNFWhOFWhNC81TyFRwTnCOciIh4E1LTGnOJUXSnMzKLq5hjh76KYW5MenFhckJqfmpZbEuwYbWZobGBmbhIQYGxOjBgB-8yW_</recordid><startdate>20240527</startdate><enddate>20240527</enddate><creator>BROWN, Zarin</creator><creator>DOMBRECHT, Bruno</creator><creator>CROMIE, Karen</creator><creator>STEFFENSEN, Soren</creator><creator>CHARLTON, Steven John</creator><creator>BRADLEY, Michelle</creator><creator>VAN HEEKE, Gino</creator><scope>EVB</scope></search><sort><creationdate>20240527</creationdate><title>Polipéptidos que se unen a CXCR2</title><author>BROWN, Zarin ; DOMBRECHT, Bruno ; CROMIE, Karen ; STEFFENSEN, Soren ; CHARLTON, Steven John ; BRADLEY, Michelle ; VAN HEEKE, Gino</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2970234TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BROWN, Zarin</creatorcontrib><creatorcontrib>DOMBRECHT, Bruno</creatorcontrib><creatorcontrib>CROMIE, Karen</creatorcontrib><creatorcontrib>STEFFENSEN, Soren</creatorcontrib><creatorcontrib>CHARLTON, Steven John</creatorcontrib><creatorcontrib>BRADLEY, Michelle</creatorcontrib><creatorcontrib>VAN HEEKE, Gino</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BROWN, Zarin</au><au>DOMBRECHT, Bruno</au><au>CROMIE, Karen</au><au>STEFFENSEN, Soren</au><au>CHARLTON, Steven John</au><au>BRADLEY, Michelle</au><au>VAN HEEKE, Gino</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Polipéptidos que se unen a CXCR2</title><date>2024-05-27</date><risdate>2024</risdate><abstract>La presente invención se refiere a polipéptidos dirigidos contra el receptor de quimiocina CXCR2 o que se unen específicamente a él y en particular a polipéptidos capaces de modular la transducción de señales a partir de CXCR2. La invención también se refiere a ácidos nucleicos, vectores y células huésped capaces de expresar los polipéptidos de la invención, composiciones farmacéuticas que comprenden los polipéptidos y usos de dichos polipéptidos y composiciones para el tratamiento de enfermedades que implican el funcionamiento aberrante de CXCR2. (Traducción automática con Google Translate, sin valor legal)
The present invention relates to polypeptides directed against or specifically binding to chemokine receptor CXCR2 and in particular to polypeptides capable of modulating signal transduction from CXCR2. The invention also relates to nucleic acids, vectors and host cells capable of expressing the polypeptides of the invention, pharmaceutical compositions comprising the polypeptides and uses of said polypeptides and compositions for treatment of diseases involving aberrant functioning of CXCR2.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2970234TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Polipéptidos que se unen a CXCR2 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T09%3A34%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BROWN,%20Zarin&rft.date=2024-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2970234TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |